Skip to main content
Caplight Logo









Hemodia

Hemodia

Private
FranceHealthcare & Life Scienceshttps://www.hemodia.com/

Last Round

Buyout/LBO

Mar 27, 2025

Company Overview

Hemodia is a medical device company that designs, manufactures, and markets single-use care kits, arthroscopy equipment, and medical accessories for hospitals and healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical device manufacturersingle-use care kitsmedical consumablesprocedure setshospital suppliesmedtech manufacturingmedical OEMcustom medical kitsarthroscopy equipmentmedical tubingenteral nutrition devicessterile medical suppliesclinical protocolsaseptic packagingsurgical equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hemodia Comparables

Compare Hemodia with similar companies based on industry and business-model similarity.

Hemodia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pennine Healthcare
84%
Kimal PLC
84%
Vygon
81%

Hemodia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOMar 27, 2025

Key People

Founding team and executive leadership

Rémi TEULIERE

Chief Executive Officer, General Manager

Executive Team

Hemodia Investors

Notable investors and investment history

Hemodia investors
InvestorRounds
iXO Private EquityBuyout/LBO
LBO FranceBuyout/LBO
BpifranceBuyout/LBO
MulticroissanceBuyout/LBO
AfricInvestBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2026

    Grew 28% QoQ, from 192 to 246 employees.

  • Mar 27, 2025

    LBO France led the buyout round with AfricInvest, Multicroissance, and Bpifrance.

Hemodia Filings

Explore SEC and related filing metadata, where available.

Hemodia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hemodia's valuation, stock price, and market status.

Is Hemodia a public or private company?

Hemodia is a private company.

What is the current stock price of Hemodia?

Hemodia is a private company with no public stock price. Caplight tracks Hemodia's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Hemodia worth (valuation)?

Valuation information for Hemodia is not publicly available.

Can I buy Hemodia stock?

Hemodia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hemodia's last funding round?

Hemodia's most recent funding round was Buyout/LBO on March 27, 2025.

Who are the main investors in Hemodia?

Key investors in Hemodia include LBO France.

Will Hemodia IPO soon?

No public IPO plans have been announced for Hemodia.

How can I track Hemodia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemodia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Employee Range248
Year Founded1985
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?